Evidence map›Paper›PMID 37488477›Full record

ArticleBMC neurology2023

Progressive arteriopathy with vasospasm in focal cerebral arteriopathy in childhood: a case report.

Takuma Nishimoto, Fumiaki Oka, Natsumi Fujii, Hirofumi Inoue, Shunji Hasegawa, Masatoshi Yamane, Sadahiro Nomura, Hideyuki Ishihara

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Takuma NishimotoDepartment of Neurosurgery, Yamaguchi University School of Medicine, 1-1-1, Minamikogushi, Ube, Yamaguchi, Yamaguchi, 755-8505, Japan. ntakuma@yamaguchi-u.ac.jp.
Fumiaki OkaDepartment of Neurosurgery, Yamaguchi University School of Medicine, 1-1-1, Minamikogushi, Ube, Yamaguchi, Yamaguchi, 755-8505, Japan.
Natsumi FujiiDepartment of Neurosurgery, Yamaguchi University School of Medicine, 1-1-1, Minamikogushi, Ube, Yamaguchi, Yamaguchi, 755-8505, Japan.
Hirofumi InoueDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Shunji HasegawaDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Masatoshi YamaneDepartment of Radiology, Yamaguchi University Hospital, Yamaguchi, Japan.
Sadahiro NomuraDepartment of Neurosurgery, Yamaguchi University School of Medicine, 1-1-1, Minamikogushi, Ube, Yamaguchi, Yamaguchi, 755-8505, Japan.
Hideyuki IshiharaDepartment of Neurosurgery, Yamaguchi University School of Medicine, 1-1-1, Minamikogushi, Ube, Yamaguchi, Yamaguchi, 755-8505, Japan.
Yamaguchi University · JPYamaguchi University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFocal cerebral arteriopathy (FCA) is a clinically important disease that often causes progressive arteriopathy. We report a case of FCA with progressive arteriopathy due to arterial shrinkage of the outer diameter found on T2-weighted three-dimensional sampling perfection with application optimized contrasts using different flip angle evolutions (3D-SPACE) imaging. CASE PRESENTATION: The patient was a 9-year-old girl who developed right hemiparesis. Acute infarction was detected in the basal ganglia. Vascular images revealed stenosis from the distal internal carotid artery (ICA) to the middle cerebral artery (MCA). Intravenous heparin was administered for 8 days, and the symptoms improved. However, 29 days after onset, right hemiparesis transiently developed again and magnetic resonance angiography (MRA) showed progressive stenosis from the ICA to MCA, while 3D-SPACE showed similar shrinkage of the outer diameter. Aspirin was started, and there was no subsequent recurrence. After 12 months, MRA and 3D-SPACE showed improvement of stenosis and arterial shrinkage.

conclusionsGiven the time course, the change in the outer diameter was thought to be vasospasm. Thus, vasospasm may be one of the causes of progressive arteriopathy in FCA.

Indexed as

Cerebrovascular DisordersVascular DiseasesAspirinChildConstriction, PathologicFemaleHumansMiddle Cerebral ArteryAspirin3D-SPACEFocal cerebral arteriopathyProgressive arteriopathyVasospasm

Identifiers

PMID37488477
PMCPMC10364366
OpenAlexW4385226955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.